Clinical trials
Active, not recruiting Phase 3 Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agios Pharmaceuticals, Inc. | 2 |
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| National Cancer Institute (NCI) | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Biocad | 1 |
| Forma Therapeutics, Inc. | 1 |
| Fudan University | 1 |
| Liverpool School of Tropical Medicine | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 16 |
| Hematologic Diseases | 4 |
| Myelodysplastic Syndromes | 4 |
| Metabolic Diseases | 2 |
| Primary Myelofibrosis | 2 |
| Renal Insufficiency, Chronic | 2 |
| Anemia, Hemolytic | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Anemia, Sickle Cell | 1 |
| Blood Platelet Disorders | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.